Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Eye (Lond) ; 23(4): 780-4, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18535597

RESUMO

AIM: To determine the incidence of endophthalmitis following 25-gauge and standard 20-gauge vitrectomy. METHODS: In this single-centre retrospective interventional case series, we evaluated the incidence of acute endophthalmitis occurring within the 14-day postoperative period in all patients who underwent pars plana vitrectomy between 1 November 2002 and 31 December 2006. A total of 3477 consecutive patients were identified. Of them, 3046 patients underwent 20-gauge vitrectomy and 431 underwent 25-gauge vitrectomy. RESULTS: The event rates of postoperative endophthalmitis were 0.03% (1 of 3046) after 20-gauge vitrectomy and 0.23% (1 of 431) after 25-gauge vitrectomy (P=0.23). In the endophthalmitis case that occurred after 25-gauge vitrectomy, a combined phacoemulsification cataract surgery was performed with the 25-gauge vitrectomy. Analyses of event rates of postoperative endophthalmitis after combining phacoemulsification cataract surgery and vitrectomy were 0% (0 of 170) for 20-gauge vitrectomy and 2.17% (1 of 46) for 25-gauge surgery vitrectomy (P=0.21). CONCLUSION: The incidence of postoperative endophthalmitis following 25-gauge vitrectomy and 20-gauge surgery is low. Although there is a trend suggesting an increased risk of endophthalmitis with the 25-gauge system, this difference was not statistically significant given the low number of measured outcomes.


Assuntos
Endoftalmite/epidemiologia , Vitrectomia/efeitos adversos , Doença Aguda , Idoso , Antibacterianos/uso terapêutico , Catarata , Endoftalmite/tratamento farmacológico , Endoftalmite/etiologia , Feminino , Humanos , Incidência , Pessoa de Meia-Idade , Cuidados Pós-Operatórios , Complicações Pós-Operatórias/epidemiologia , Estudos Retrospectivos , Resultado do Tratamento , Acuidade Visual , Vitrectomia/instrumentação , Vitrectomia/métodos
2.
Br J Ophthalmol ; 91(1): 111-5, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17179125

RESUMO

We report a case of bilateral mitochondrial optic neuropathies secondary to long-term linezolid treatment, show the nature of recovery, review the findings in the literature and propose a potential mitochondrial mechanism for linezolid-induced mitochondrial optic neuropathy. This is an observational case report and literature review with presentation of the clinical course of linezolid mitochondrial optic neuropathies through clinical and psychophysical documentation. Main outcome measures included: visual acuity, funduscopical examinations and peripapillary retinal nerve fibre layer (PRNFL) optical coherence tomography (OCT). A 6-year-old boy presented with bilateral optic neuropathies secondary to 1 year of linezolid treatment for osteomyelitis of the mandible. On presentation, visual acuities were 20/400 in both eyes, with considerable optic disc oedema, hyperaemia and PRNFL swelling confirmed by OCT. 2 weeks after the discontinuation of linezolid, visual acuities returned to 20/25 in both eyes, with reduction in the optic disc oedema, hyperaemia and PRNFL swelling. 3 months after the discontinuation of linezolid treatment, visual acuities were stable at 20/20 in both eyes, with a marked decrease in PRNFL swelling confirmed by OCT, and the development of mild temporal optic disc pallor in both eyes. Doctors should be aware of impairments of vision among patients on long-term linezolid treatment and promptly discontinue treatment to prevent irreversible vision loss. The development and resolution of bilateral optic neuropathies with considerable PRNFL swelling in this patient provide insight into the more general rubric of mitochondrial optic neuropathies.


Assuntos
Acetamidas/efeitos adversos , Anti-Infecciosos/efeitos adversos , Doenças do Nervo Óptico/induzido quimicamente , Oxazolidinonas/efeitos adversos , Criança , Angiofluoresceinografia/métodos , Humanos , Linezolida , Masculino , Doenças Mandibulares/tratamento farmacológico , Doenças Mitocondriais/induzido quimicamente , Fibras Nervosas/efeitos dos fármacos , Osteomielite/tratamento farmacológico , Retina/efeitos dos fármacos , Transtornos da Visão/induzido quimicamente , Acuidade Visual/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA